Literature DB >> 27002229

Congenital cardiac surgery fellowship training: A status update.

Brian Kogon1, Tara Karamlou2, William Baumgartner3, Walter Merrill4, Carl Backer5.   

Abstract

BACKGROUND: In 2007, congenital cardiac surgery became a recognized fellowship by the Accreditation Council of Graduate Medical Education (ACGME) and leads to board certification through the American Board of Thoracic Surgery (ABTS). We highlight the strengths and weaknesses in the current system of accredited training.
METHODS: Data were collected from program directors, the ACGME, and the ABTS. In addition, surveys were sent to training program graduates. Topics included program accreditation status, number of fellows trained per year and per program, match results, fellow operative experience, fellow satisfaction, and post-fellowship employment status.
RESULTS: There are twelve active accredited fellowship programs, and 44 trainees have completed accredited training. Each active program has trained a median of 3 fellows (range: 0-7). Operative logs were obtained from 38 of 44 (86%) graduates. The median number of total cases (minimum 75) was 136 (range: 75-236). For complex neonates (minimum 5), the median number of cases was 6 (range: 2-17). Some fellows failed to meet the minimum requirements. Thirty-six (82%) graduates responded to the survey; most were satisfied with their overall operative experience, but less with their neonatal operative experience. Of this total, 84% are currently practicing congenital cardiac surgery, and 74% secured jobs prior to completing their residency.
CONCLUSIONS: Since 2007, congenital cardiac surgery training has been accredited by the ACGME. In general, the training is uniform, the operative experience is robust, and the fellows are satisfied. Although shortcomings remain, this study highlights the many strengths of the current system.
Copyright © 2016 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital cardiac surgery; fellowship training

Mesh:

Year:  2016        PMID: 27002229     DOI: 10.1016/j.jtcvs.2016.02.039

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Proximalized Total Arch Replacement Can Be Safely Performed by Trainee.

Authors:  Sentaro Nakanishi; Naohiro Wakabayashi; Hayato Ise; Hiroto Kitahara; Aina Hirofuji; Natsuya Ishikawa; Hiroyuki Kamiya
Journal:  Thorac Cardiovasc Surg       Date:  2020-07-07       Impact factor: 1.827

Review 2.  Pediatric Cardiac Service Development Programs for Low- and Middle-Income Countries in Need of Improving or Initiating Local Services.

Authors:  William M Novick; Frank Molloy; Karen Bowtell; Brian Forsberg; Martina Pavanić; Igor Polivenok; Sri Rao; Yamile Muñoz; Marcelo Cardarelli
Journal:  Front Pediatr       Date:  2019-09-20       Impact factor: 3.418

3.  Health Care Policy and Congenital Heart Disease: 2020 Focus on Our 2030 Future.

Authors:  Devyani Chowdhury; Jonathan N Johnson; Carissa M Baker-Smith; Robert D B Jaquiss; Arjun K Mahendran; Valerie Curren; Aarti Bhat; Angira Patel; Audrey C Marshall; Stephanie Fuller; Bradley S Marino; Christina M Fink; Keila N Lopez; Lowell H Frank; Mishaal Ather; Natalie Torentinos; Olivia Kranz; Vivian Thorne; Ryan R Davies; Stuart Berger; Christopher Snyder; Arwa Saidi; Kenneth Shaffer
Journal:  J Am Heart Assoc       Date:  2021-10-08       Impact factor: 5.501

4.  State-of-the-art silicone molded models for simulation of arterial switch operation: Innovation with parting-and-assembly strategy.

Authors:  Brandon Peel; Whal Lee; Nabil Hussein; Shi-Joon Yoo
Journal:  JTCVS Tech       Date:  2022-01-19

5.  Clinical translation of surgical simulated closure of a ventricular septum defect.

Authors:  Qi Li; Nabil Hussein; Yunyi Zhang; Yibing Fang; Yue Wang; Qi An; Osami Honjo; Shuhua Luo
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-08-03

Review 6.  Congenital Heart Surgery Skill Training Using Simulation Models: Not an Option but a Necessity.

Authors:  Shi-Joon Yoo; Nabil Hussein; David J Barron
Journal:  J Korean Med Sci       Date:  2022-10-03       Impact factor: 5.354

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.